Current role
Esther Cho
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Keros Therapeutics, Inc. (KROS)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Keros Therapeutics, Inc. (KROS) | Esq. Chief Legal Officer Christopher Rovaldi Former President and Chief Operating Officer | $459,192 | $1,098,832 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.